International Academy of Cardiology Annual Scientific Sessions 2019 - 24th World Congress on Heart Disease

  • 26-28 July 2019
  • Hyatt Regency Vancouver, Canada

The International Academy of Cardiology Annual Scientific Sessions 2019 - 24th World Congress on Heart Disease covers topics such as:

  • DIAGNOSTIC METHODS
    • Transesophageal echocardiography
    • Biochemical markers of acute ischemia
    • Echocardiography, three-dimensional reconstruction
    • Pharmacologic stress testing - echocardiography
    • PET - new insights into myocardial metabolism
    • Nuclear cardiology - new techniques to assess cardiac perfusion, function and viability
    • CT and coronary calcification
    • Applications of cardiac magnetic resonance imaging
    • Intravascular ultrasound imaging
    • Percutaneous coronary angioscopy
    • Intracoronary flow, doppler measurements
  • MOLECULAR CARDIOLOGY, BASIC RESEARCH
    • Oxidative stress and anti-oxidant therapy
    • Apoptosis in vascular and cardiac remodeling
    • Genetic studies in cardiomyopathy
    • Genetic determinants of coronary heart disease
    • The pathogenesis of atherosclerosis
    • Gene transfer and therapy
    • Immunological principles in coronary artery disease
    • Extracellular matrix and atherosclerosis
    • Neointimal hyperplasia and vascular injury
    • Growth control and cytokines in vascular cells
    • Pharmacologic modulation of vascular-endothelial function
  • HEART FAILURE
    • Nitric oxide and nitric oxide synthase in heart failure
    • Neurohumoral, immunologic and cytokine aspects of heart failure
    • Natriuretic peptides, endothelin: role in heart failure
    • Myocyte and receptor abnormalities in heart failure
    • Dilated cardiomyopathy: various etiologies
    • Inflammatory mediators and heart failure
    • Left ventricular hypertrophy and hypertrophic cardiomyopathy
    • Ischemic cardiomyopathy
    • Pathophysiologic and prognostic insights in valvular heart disease
    • Role of the pericardium, pericarditis and restrictive cardiomyopathy
    • Predictors and markers of heart failure outcome
    • Pulmonary circulation aspects, pulmonary hypertension
    • Renal aspects - diuretics
    • Exercise physiology in heart failure
    • ACE inhibitors and Angiotensin-ll receptor blockers
    • Digoxin and other new inotropic agents in heart failure
    • Calcium channel blockers and promoters in heart failure
    • Beta-blockers and beta-adrenergic receptors in heart failure
    • Cardiac pacing strategies in heart failure
  • CORONARY ARTERY DISEASE
    • Mechanisms involved in myocardial stunning, hibernation and ischemic preconditioning
    • The plaque and acute coronary syndromes
    • Angioplasty therapy for acute myocardial infarction
    • Acute myocardial infarction: thrombolysis and reperfusion
    • Antithrombotic and antiplatelet adjunctive therapy for PTCA
    • Stents: new devices/optimal application/multiple stents
    • Restenosis - use of ionizing radiation
    • Blockade of tissue proliferation after coronary interventions
    • Left ventricular remodeling after myocardial infarction
    • Nitrates, beta blockers, calcium entry blockers and ACE inhibition for myocardial ischemia/infarction
    • Secondary prevention, risk stratification
    • Assessment of prognosis, post acute myocardial infarction
    • Can the progress of atherosclerosis be halted?
    • Cardiac rehabilitation as secondary prevention: is it worth the effort?
    • Hypertension, new therapeutic approaches
    • Modification of lipoproteins and coronary disease
    • Mental stress: its effect on cardiovascular health
    • Diabetes mellitus, obesity, insulin and atherosclerosis
    • Hormone therapy in postmenopausal women: does it alter coronary risk?
    • Primary prevention of coronary artery disease in the healthy adult
    • Prevention in children
  • CARDIAC SURGERY
    • Angioplasty or surgery for multivessel coronary artery disease
    • Advances in congenital heart disease
    • Therapeutic and physiologic issues surrounding heart valve surgery
    • New approaches to surgical revascularization: Minimally invasive surgery, TMLR
    • Surgery for LV dysfunction
    • Mechanical support left ventricular assist devices
    • Cardiac transplantation
  • ARRHYTHMIAS
    • Atrial flutter/fibrillation - electrophysiologic concepts and clinical aspects
    • Arrhythmias and antiarrhythmic drug therapy
    • Heart rate variability and prognostic implications
    • Management of cardiac arrhythmias pediatric population
    • Sudden death
    • QT prolongation/dispersion: pathophysiology and prognostic implications
    • Advances in internal defibrillation and implantable antiarrhythmic devices
    • Electrophysiologic techniques of mapping and radiofrequency ablation
    • Cardiac Pacing
  • MISCELLANEOUS
    • Computers in cardiology
    • Practice guidelines, cost containment

The International Academy of Cardiology Annual Scientific Sessions 2019 - 24th World Congress on Heart Disease will be held in Vancouver, Canada on 26-28 July 2019.

Venue

Hyatt Regency Vancouver
655 Burrard Street ,
Vancouver,
Canada
  View all Hotels near Venue
Booking.com
460-790 US Dollar
Included
International Academy of Cardiology (Cardioligy Online)
Rentalcars Savings

Past and Future Events

  • International Academy of Cardiology Annual Scientific Sessions 2020 - 25th World Congress on Heart Disease - Jul 2020, Boston, United States (32688)
  • International Academy of Cardiology Annual Scientific Sessions 2019 - 24th World Congress on Heart Disease - 26-28 Jul 2019, Vancouver, Canada (22131)
  • International Academy of Cardiology Annual Scientific Sessions 2018 - 23rd World Congress on Heart Disease - 27-29 Jul 2018, Boston, United States (22130)

Important

Please, check the official conference website for possible changes, before you make any traveling arrangements

Prices are for evaluation only.